Company Overview of Amaran Biotechnology, Inc.
Amaran Biotechnology, Inc. develops and manufactures glycoprotein drugs for breast cancer. The company offers Haoding (OBI Pharma) Advanced Metastatic Breast Cancer Drugs OBI-822 and OBI-821. Amaran Biotechnology, Inc. was founded in 2010 and is based in Zhubei City, Taiwan.
No. 19 Shengyi 5th Road
Zhubei City, 30261
Founded in 2010
Key Executives for Amaran Biotechnology, Inc.
Amaran Biotechnology, Inc. does not have any Key Executives recorded.
Amaran Biotechnology, Inc. Key Developments
Similar Private Companies By Industry
|Amaran Biotechnology, Inc.||Asia|
|Anteluo Biological Technology Co., Ltd.||Asia|
|Aviles Bio-Technology Co., Ltd.||Asia|
|Cathay Biotech Co., Ltd.||Asia|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Amaran Biotechnology, Inc., please visit www.amaran.com.tw. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.